We could not find any results for:
Make sure your spelling is correct or try broadening your search.
The current AIM market cap is 23.44M. The company's latest EPS is USD -0.3981 and P/E is -4.52.
Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Revenue | 21k | 56k | 49k | 42k | 46k |
Operating Income | -6.61M | -5.56M | -4.3M | -5.46M | -8.16M |
Net Income | -6.39M | -4.39M | -3.66M | -4.91M | -7.82M |
Year End December 30 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Revenue | 367k | 140k | 163k | 135k | 141k |
Operating Income | -11.5M | -12.44M | -15.02M | -17.06M | -19.92M |
Net Income | -9.81M | -9.53M | -14.4M | -19.13M | -19.45M |
Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Assets | 46.29M | 40.49M | 37.46M | 33.62M | 27.86M |
Total Liabilities | 3.59M | 2.02M | 2.47M | 3.48M | 5.26M |
Total Equity | 42.7M | 38.47M | 34.99M | 30.14M | 22.6M |
Year End December 30 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Assets | 13.85M | 20.22M | 64.58M | 57.7M | 40.49M |
Total Liabilities | 8.67M | 7.31M | 3.29M | 820k | 2.02M |
Total Equity | 5.17M | 12.91M | 61.29M | 56.88M | 38.47M |
Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Operating | -10.04M | -16.11M | -3.68M | -5.84M | -11.51M |
Investing | 7.63M | 10.99M | -78k | -282k | -618k |
Financing | 80k | 80k | 100k | 105k | 338k |
Year End December 30 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Operating | -10.64M | -9.07M | -10.37M | -13.97M | -16.11M |
Investing | 92k | -6.15M | -9.16M | -631k | 10.99M |
Financing | 9.44M | 16.39M | 56.56M | 8.19M | 80k |
Market Cap | 23.44M |
Price to Earnings Ratio | -4.52 |
Price to Sales Ratio | 620.69 |
Price to Cash Ratio | 3.25 |
Price to Book Ratio | 2.29 |
Dividend Yield | - |
Shares Outstanding | 48.84M |
Average Volume (1 week) | 302.53k |
Average Volume (1 Month) | 367.04k |
52 Week Change | 0.00% |
52 Week High | 0.7487 |
52 Week Low | 0.3201 |
Spread (Intraday) | 0.04 (8.33%) |
Company Name | AIM ImmunoTech Inc |
Address |
251 little falls drive wilmington, delaware 19808 |
Website | https://www.aimimmuno.com |
Industry | biological pds,ex diagnstics (2836) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions